Delpor on track with schizophrenia implant late-stage trials
Delpor is sketching out late-stage clinical trial plans for its drug-device combination implant DLP-114 (risperidone) in schizophrenia. After presenting topline…
Delpor is sketching out late-stage clinical trial plans for its drug-device combination implant DLP-114 (risperidone) in schizophrenia. After presenting topline…
After a few years of disruption caused by the Covid-19 pandemic, it seems that the pharma and biotech industries can…
US-based endovascular company Synchron has completed patient enrolment in its brain-computer interface (BCI) clinical trial. The company is developing implantable…
The clinical trial industry is re-evaluating the benefits of decentralisation as decentralised clinical trials (DCTs) are coming down the pedestal.…
Digital biomarkers can potentially open new doors in clinical research. By using digital sensors or other forms of non-traditional digital…